Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2007-004001-96Phase 4Active
Phase 4, open-label trial of deferiprone and idebenone in Friedreich ataxia (FA) (2 arms), sponsored by Sant Joan de Déu Hospital. Primary endpoint: Exclusion criteria occurrence during the trial. Started Mar 2010; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2007-004001-96.